- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on MS (Multiple Sclerosis)
Total 9962 results
-
Trio Medicines Ltd.BiogenCompleted
-
BiogenTerminatedMultiple Sclerosis (MS)Germany
-
Jazz PharmaceuticalsTerminatedMultiple Sclerosis (MS)United States, Poland, Czechia, United Kingdom, Romania
-
Sheikh Shakhbout Medical CityRecruitingSpasticity, Muscle | Oxygen Consumption | Sclerosis, Multiple | Spastic | MS (Multiple Sclerosis)United Arab Emirates
-
US Department of Veterans AffairsCompletedMS (Multiple Sclerosis)United States
-
Tel-Aviv Sourasky Medical CenterUnknownTo Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS
-
University of Wisconsin, MadisonNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Enrolling by invitationMultiple Sclerosis | MSUnited States
-
DxTerity DiagnosticsUnknownMultiple Sclerosis | MSUnited States
-
Merck KGaA, Darmstadt, GermanyEMD Inc., CanadaCompletedMultiple Sclerosis | MSCanada
-
October 6 UniversityCompletedVestibular Rehabilitation in MSEgypt
-
Brown, Theodore R., M.D., MPHEvergreen HealthcareCompletedErythema | MS (Multiple Sclerosis)United States
-
University at BuffaloUniversity of PaviaCompletedMultiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Other Neurological Disorders (OND) | Healthy (HC)
-
Qilu Hospital of Shandong UniversityUnknownMS (Multiple Sclerosis) | NMO Spectrum Disorder
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
Hadassah Medical OrganizationWithdrawnMS Patient With Relpasing Remitting AttacksIsrael
-
University of California, San FranciscoUnited States Department of DefenseRecruitingDepression | Multiple Sclerosis | MSUnited States
-
Columbia UniversityCompletedCOVID-19 | MS (Multiple Sclerosis) | Support GroupsUnited States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Stony Brook UniversityNovartisCompletedMultiple Sclerosis | Cognitive Deficits | Gilenya Modifying Therapy for MSUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Synergy Health Concepts, Inc.UnknownVenous Irregularities, Flow and Perfusion in MS and Non-MS ParticipantsUnited States
-
BayerCompletedSecondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)Portugal
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis | Relapsing Forms of Multiple Sclerosis
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Johns Hopkins UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Novartis PharmaceuticalsTerminatedRelapse Remitting Multiple SclerosisUnited States, Ukraine, Czechia
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more